Buy Byetta 250 ug/mL exenatide

Byetta 250 ug/mL is a subcutaneous injection containing exenatide, used for managing type 2 diabetes. This medication helps control blood sugar levels and is administered via a pre-filled cartridge.

Strength

250 ug/mL

Pack Size

1 CARTRIDGE in 1 CARTON (0310-6512-01) / 1.2 mL in 1 CARTRIDGE

Manufacturer / TM Owner

AstraZeneca Pharmaceuticals LP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Byetta 250 ug/mL is primarily used for managing type 2 diabetes. It works by mimicking natural hormones in the body to lower blood sugar levels. This medication is often prescribed as part of a comprehensive diabetes management plan, which may include diet and exercise. Byetta is not typically used for type 1 diabetes or diabetic ketoacidosis.

Side Effects

Common effects of Byetta 250 ug/mL may include nausea, vomiting, diarrhea, and injection site reactions. Some users may experience low blood sugar, especially when combined with other diabetes medications. It is important to monitor blood sugar levels regularly while using this medication.

Precautions & Warnings

Byetta 250 ug/mL should be stored at room temperature and protected from light. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Do not share this medication with others, even if they have similar symptoms.

Avoid Interactions

Byetta 250 ug/mL may interact with other medications, including those that lower blood sugar, such as insulin or sulfonylureas. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated, as it can affect blood sugar levels.

References

Frequently Asked Questions

Byetta 250 ug/mL is used for managing type 2 diabetes by helping to control blood sugar levels.

Byetta 250 ug/mL is administered via subcutaneous injection using a pre-filled cartridge.

Common side effects may include nausea, vomiting, diarrhea, and injection site reactions.

No, Byetta 250 ug/mL is not typically used for type 1 diabetes or diabetic ketoacidosis.

Byetta 250 ug/mL should be stored at room temperature and protected from light.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.